Veracyte, Inc. (VCYT) NASDAQ
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Veracyte, Inc.
Address
6000 Shoreline Court
South San Francisco, CA 94080
United States of America (the)
Phone
650 243 6300
Website
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
755
First IPO Date
October 29, 2013
Key Executives
| Name | Title | Pay | Year Born |
| Marc A. Stapley | Chief Executive Officer & Director | 1.53M | 1970 |
| Annie McGuire | Executive VP, General Counsel & Head of Market Access | 829,500 | 1980 |
| John Leite | Global Chief Commercial Officer | 846,485 | 1972 |
| Rebecca Chambers | Executive Vice President & Chief Financial Officer | 911,950 | 1978 |
| Phillip G. Febbo | Chief Scientific & Medical Officer | 930,089 | 1966 |
| Keith Gligorich | Senior Vice President of Global Operations | 0 | N/A |
| Kevin Richard Haas | Chief Development and Technology Officer | 0 | 1985 |
| Jonathan Wygant | Vice President & Chief Accounting Officer | 0 | 1971 |
| Steven French | Senior Vice President & Chief Information Officer | 0 | N/A |
| Kelly Gura | Director of Investor Relations | 0 | N/A |
Description
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
